Abstract:
Epstein-Barr virus infection is one of the
most common human diseases. According to WHO,
approximately 55-60% of young children (under 3 years
of age) are infected with Epstein-Barr virus (EBV). Most
of the adult population on the planet (90-98%) have
EBV antibodies [1,3,5]. In different countries of the
world, the incidence varies from 3-5 to 45 cases per
100,000 inhabitants, and this is a higher rate. EBV
belongs to the group of uncontrolled infections. It does
not have specific prevention (vaccination) [4,8,10,11].
The source of EBV infection is a patient who has a
clinical picture and is a carrier of the virus. Up to 20%
of patients are infectious during the last days of the
incubation period, during the initial period of the
disease, as well as during the entire recovery period (up
to 6 months after recovery). That is, even those who
have recovered from the disease occasionally retain
their ability to release the virus (carrier)[6,7,12]. EBV
can be transmitted to the body through contact with the
air, the patient's personal belongings, toys, eating
utensils and saliva
